By MLex Staff ( November 27, 2024, 06:56 GMT | Insight) -- Investigating monopolistic practices in the pharmaceutical sector poses significant challenges, a veteran local Chinese antitrust enforcer told a recent competition conference. Since these violations are intentional, monopolistic tactics and schemes are becoming increasingly sophisticated, said Suo Zhongle, a senior official at the Jiangsu branch of China's State Administration for Market Regulation.Investigating monopolistic practices in the pharmaceutical sector poses significant challenges, a veteran local Chinese antitrust enforcer told a recent competition conference.*...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.